- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 08, 2024, 03:02:32 PM
- Local Time:
- May 30, 2024, 01:58:23 PM
- Last Active:
- May 08, 2024, 08:16:46 PM
Signature:
AS03 as well as MF59-adjuvanted H5N8 IIV created robust immunogenic responses pursuing two dosages. There was very poor cross-reactivity to the three